We are live on ! Find out more
EVO icon

Evotec
EVO

19 hedge funds and large institutions have $14.5M invested in Evotec in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.35% less ownership

Funds ownership: 0.74% → 0.39% (-0.35%)

14% less funds holding

Funds holding: 22 → 19 (-3)

31% less capital invested

Capital invested by funds: $21.1M → $14.5M (-$6.53M)

67% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 9

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
19
Holders Change
-3
Holders Change %
-13.64%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DA
DCF Advisers
Connecticut
+$118K
2
Optiver Holding
Optiver Holding
Netherlands
+$63.1K
3
Bank of America
Bank of America
North Carolina
+$4.62K
4
Morgan Stanley
Morgan Stanley
New York
+$2.84K

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$9.3M
2
Renaissance Technologies
Renaissance Technologies
New York
-$255K
3
Jane Street
Jane Street
New York
-$162K
4
OMC
Old Mission Capital
Illinois
-$108K
5
Citadel Advisors
Citadel Advisors
Florida
-$107K

EVO Hedge Fund Activity: Q1 2023 in Review

19 of the 6,284 institutional investors tracked by Wall St. Rank reported a position in Evotec (EVO) for Q1 2023, worth a combined $14.5M — down 31% from $21.1M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of EVO and 1 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 3 added.

The largest buyer was DCF Advisers, opening a new position worth an estimated $118K. The largest seller was Artal Group, exiting entirely with an estimated $9.3M sold.

  • 19 institutional investors held Evotec (EVO) as of Q1 2023, down from 22 in Q4 2022.
  • Funds reported $14.5M of Evotec stock for Q1 2023, down 31% quarter-over-quarter.
  • 1 fund opened new Evotec positions in Q1 2023 and 4 closed out, a net change of -3 holders.
  • The largest Evotec buyer in Q1 2023 was DCF Advisers, an estimated $118K added.
  • The largest Evotec seller in Q1 2023 was Artal Group, an estimated $9.3M sold.

Based on aggregated 13F filings for Q1 2023.